Physician profile
Michael C Mcdaniel
NPI 1720264765
$2,010.97
in general payments reported to CMS, 2019-2025
18 companies · $1,354 in 2025
The $1,354 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $30.23 · 2021: $115 · 2022: $166 · 2023: $18.51 · 2024: $328 · 2025: $1,354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,225 · Food and Beverage: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,225.00 |
| Food and Beverage | $475.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,225.00 | 2024-2025 | Indigo System |
| Abiomed | $150.00 | 2022 | |
| Abbott Laboratories | $106.79 | 2025 | Optis |
| Stryker Corporation | $64.23 | 2025 | Flowtriever |
| Livanova USA, INC. | $59.31 | 2021 | |
| Angiodynamics, INC. | $50.91 | 2024 | Alphavac |
| Optumhealth Care Solutions, LLC | $50.45 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Boston Scientific Corporation | $45.48 | 2020-2025 | Lux-Dx Insertable Cardiac Monitor |
| Inari Medical, INC. | $45.41 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Acist Medical Systems, INC. | $44.03 | 2024 | |
| Imperative Care, INC | $29.53 | 2025 | Symphony Catheter |
| Janssen Pharmaceuticals, INC | $29.13 | 2021-2022 | |
| Baxter Healthcare | $22.72 | 2025 | Seprafilm |
| Philips North America LLC | $22.10 | 2021 | |
| W. L. Gore & Associates, INC. | $20.16 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $18.51 | 2023 | |
| Chiesi USA, INC. | $14.63 | 2025 | Kengreal |
| Mayne Pharma Commercial LLC | $12.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcdaniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.